Literature DB >> 22288328

Knowledge and attitudes of secondary school students in Federal Capital Territory (FCT), Abuja, Nigeria towards sickle cell disease.

Rotimi S Owolabi1, Peter Alabi, Daniel Olusoji, Samuel Ajayi, Theresa Otu, Adeniyi Ogundiran.   

Abstract

BACKGROUND: This study was conducted among Secondary School Students in Federal Capital Territory (FCT),Abuja Nigeria, between May and June 2010 to determine the knowledge and attitudes of the students towards Sickle Cell Disease (SCD).
METHODS: The study was a cross-sectional study carried out on 600 students from 8 secondary schools located within (FCT). A multistage sampling method was used for selection of the study population. Data was collected with the aid of a pretested self-administered questionnaire and analyzed with EPI-INFO 2008.
RESULTS: The age of respondents ranged from 9 to 26 years with the mean age of 15.16 (SD = 2.13). The modal age of the respondents was 10-19 years (97.8%). The male: female ratio was 1.01:1. A large number of respondents' fathers (80.7%) and mothers (70.2%) respectively, had at least secondary school education. Majority (81.8%) of the respondents claimed to have heard about sickle cell disease (SCD) but only 38.0% of them knew the cause of SCD. Slightly less than half, 292 (48.7%) of the respondents knew their genotype. Of the 292 respondents that knew their genotype, 206 (70.5%) were AA, 50 (17.1%) were AS,14 (4.8%), SS, 11 (3.8%)AC, 5 (1.7%) SC, 4 (1.4%) CC, 2 (0.7%) other types of genotype. Only 46.2% and 36.8% of them respectively, correctly identified that pre-marital genotype testing and avoidance of marriage between two persons with haemoglobin S genotype as means of preventing further spread of SCD. Factors found to be significantly associated with the knowledge of respondents' genotype were; age = 15 years, respondents' mothers' educational status, being taught about SCD in school, ever seeing somebody suffering from SCD complication, losing a relative to SCD, being in senior secondary school class and knowing the cause of SCD.
CONCLUSION: This study shows that majority of the respondents did not know their genotype ,and their knowledge about the cause and prevention of SCD was poor.

Entities:  

Mesh:

Year:  2011        PMID: 22288328

Source DB:  PubMed          Journal:  Niger J Med        ISSN: 1115-2613


  7 in total

1.  Knowledge and awareness of personal sickle cell genotype among parents of children with sickle cell disease in southeast Nigeria.

Authors:  O U Ezenwosu; B F Chukwu; A N Ikefuna; A T Hunt; J Keane; I J Emodi; E E Ezeanolue
Journal:  J Community Genet       Date:  2015-04-14

2.  How people in Benin assess a couple's risk of having a baby with sickle cell disease.

Authors:  Ornheilia Zounon; Paul Clay Sorum; Etienne Mullet
Journal:  J Community Genet       Date:  2014-11-25

3.  Knowledge and awareness of sickle cell disease: a cross sectional study amongst unmarried adults in Nigeria's capital city.

Authors:  Obi Peter Adigwe
Journal:  J Community Genet       Date:  2022-09-28

4.  Knowledge and attitude of secondary school students in Jos, Nigeria on sickle cell disease.

Authors:  Olarewaju Sunday Olakunle; Enwerem Kenneth; Adebimpe Wasiu Olakekan; Olugbenga-Bello Adenike
Journal:  Pan Afr Med J       Date:  2013-08-08

5.  Sickle cell disease prevention: How prepared are the senior secondary school students in Surulere Local Government Area, Lagos, Nigeria?

Authors:  Oluchi J Kanma-Okafor; Adetola O Abolarinwa; Omobola Y Ojo; Ekanem E Ekanem
Journal:  Afr J Prim Health Care Fam Med       Date:  2022-04-19

Review 6.  Hypertransfusion therapy in sickle cell disease in Nigeria.

Authors:  Ademola Samson Adewoyin; Jude Chike Obieche
Journal:  Adv Hematol       Date:  2014-08-07

7.  Knowledge, attitude and control practices of sickle cell diseases among senior secondary students in Osun State, Nigeria.

Authors:  Adeyemo Deborah Oluwadamilola; Temidayo Ifeoluwa Akinreni; Moshood Adekunle Adefisan; Seun Deborah Olayiwola
Journal:  Pan Afr Med J       Date:  2021-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.